NCT05241873 2025-02-10(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion MutationsBlueprint Medicines CorporationPhase 1 Terminated103 enrolled
NCT05153408 2023-06-18(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCBlueprint Medicines CorporationPhase 1 Terminated20 enrolled
NCT00599755 2018-01-16Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)Merck Sharp & Dohme LLCPhase 1 Completed68 enrolled 12 charts
NCT00654758 2017-11-21A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)AbbViePhase 1 Completed33 enrolled
NCT00513383 2017-03-01Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and NeckMassachusetts General HospitalPhase 1 Completed34 enrolled
NCT01253681 2015-10-14Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerAmgenPhase 1 Completed27 enrolled
NCT01016054 2013-02-27A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian CancerAstellas Pharma IncPhase 1 Terminated4 enrolled
NCT00666692 2012-04-27A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)AbbottPhase 1 Completed7 enrolled